AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Company of heroes 3 pacific11/14/2023 ![]() ![]() Under the agreement, Pfizer will begin work to increase manufacturing capacity by 65%. The collaboration is an extension of a partnership that first began in 2014. In addition to all the advantages for women, it is also helping the National Family Planning Program in its efforts toward achieving the Family Planning 2030 goal of reaching modern Contraceptive Prevalence Rate of 60%." ![]() “We, as Malawi Ministry of Health, are glad that we are part of the roll out. ![]() "DMPA-SC3 is a unique product with multifaceted benefits,” said Fannie Kachale, Director Reproductive Health Services in the Malawi Ministry of Health. According to a 2022 study, one in 14 women worldwide who want to use contraceptives cannot access them.2 This amounts to an unmet need of 162 million women, the majority of whom live in sub-Saharan Africa and South Asia. Poor access to contraceptives presents a significant burden for women living in low- and middle-income countries. The update allows for increased manufacturing capacity and also sees an additional 23 eligible countries added to the program. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer’s injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)1 administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030. NEW YORK (AUGUST 3, 2023) - To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced today the expansion of their nearly decade-long collaboration. Previously guaranteed pricing of $0.85 per unit will be maintained for public-sector purchasers in low-income and lower-middle income countriesĬollaboration builds on agreement first established in 2014 that has provided contraceptive options to millions of women in low and lower middle-income countries to date Increased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery of more than 320 million doses through 2030 ![]()
0 Comments
Read More
Leave a Reply. |